Halozyme Therapeutics (HALO) Tops Q4 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. SWKS
7. ANET
8. SPY
9. XYZ
10. CVS

Go back to Halozyme Therapeutics (HALO) Tops Q4 EPS by 11c

Halozyme Reports Fourth Quarter And Full Year 2015 Financial Results

February 29, 2016 4:05 PM EST

SAN DIEGO, Feb. 29, 2016 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the fourth quarter and full year ended December 31, 2015, which included a fourth quarter increase in royalty revenue of 136 percent from the prior year period and net income of $4.3 million, or $0.03 per share, compared to a net loss in the fourth quarter of 2014 of $5.3 million, or $0.04 per share.  For the full year, total revenue increased 79 percent to $135.1 million compared to $75.3 million in the prior year.

"We closed 2015 with record progress across both pillars of our strategy... More